p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-1596
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations ; volume:17 ; number:1 ; day:5 ; month:12 ; year:2022 ; pages:1-9 ; date:12.2022
Diagnostic pathology ; 17, Heft 1 (5.12.2022), 1-9, 12.2022
- Urheber
-
Sung, You-Na
Kim, Deokhoon
Kim, Jihun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13000-022-01273-w
- URN
-
urn:nbn:de:101:1-2023021522132743644753
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sung, You-Na
- Kim, Deokhoon
- Kim, Jihun
- SpringerLink (Online service)
Ähnliche Objekte (12)
The pattern-based interpretation of p53 immunohistochemical expression as a surrogate marker for TP53 mutations in colorectal cancer
p53 protein expression patterns associated with TP53 mutations in breast carcinoma
Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma
TP53 mutations in Romanian patients with colorectal cancer
Expression signatures of TP53 mutations in serous ovarian cancers
Functional classification of TP53 mutations in acute myeloid leukemia
Impact of TP53 mutations in Triple Negative Breast Cancer
Clinical implications of germline mutations in breast cancer: TP53
Endometrial carcinomas with ambiguous histology often harbor TP53 mutations
Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations
Prognostic and predictive value of TP53 mutations in pediatric medulloblastoma
The pattern-based interpretation of p53 immunohistochemical expression as a surrogate marker for TP53 mutations in colorectal cancer
p53 protein expression patterns associated with TP53 mutations in breast carcinoma
Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma
TP53 mutations in Romanian patients with colorectal cancer
Expression signatures of TP53 mutations in serous ovarian cancers
Functional classification of TP53 mutations in acute myeloid leukemia
Impact of TP53 mutations in Triple Negative Breast Cancer
Clinical implications of germline mutations in breast cancer: TP53
Endometrial carcinomas with ambiguous histology often harbor TP53 mutations
Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations
Prognostic and predictive value of TP53 mutations in pediatric medulloblastoma
The pattern-based interpretation of p53 immunohistochemical expression as a surrogate marker for TP53 mutations in colorectal cancer
p53 protein expression patterns associated with TP53 mutations in breast carcinoma
Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma
TP53 mutations in Romanian patients with colorectal cancer
Expression signatures of TP53 mutations in serous ovarian cancers
Functional classification of TP53 mutations in acute myeloid leukemia
Impact of TP53 mutations in Triple Negative Breast Cancer
Clinical implications of germline mutations in breast cancer: TP53
Endometrial carcinomas with ambiguous histology often harbor TP53 mutations
Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations